Immatics (IMTX) Depreciation & Amortization (CF) (2019 - 2025)
Immatics (IMTX) reported Depreciation & Amortization (CF) of $3.7 million for Q4 2025, up 12.23% on a YoY basis from $3.3 million in Q4 2024, and up 2.95% sequentially from $3.6 million in Q3 2025.
Immatics (IMTX) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $3.7 million in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 12.23% year-over-year to $3.7 million; the trailing twelve-month figure through Dec 2025 stood at $14.0 million (up 5.8% YoY), and the FY2025 full-year result was $14.0 million, up 5.88% from the prior year.
- Depreciation & Amortization (CF) improved to $3.7 million in Q4 2025, from $3.6 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.7 million in Q4 2025 to a low of -$5.8 million in Q4 2023.
- A 5-year average of $2.0 million and a median of $2.0 million in 2021 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) sank 427.09% in 2023 and surged 156.32% in 2024, its largest moves.
- Tracing IMTX's Depreciation & Amortization (CF) over 5 years: stood at $1.5 million in 2021, then advanced by 20.64% to $1.8 million in 2022, then slumped by 427.09% to -$5.8 million in 2023, then surged by 156.32% to $3.3 million in 2024, then climbed by 12.23% to $3.7 million in 2025.
- Business Quant data shows IMTX's Depreciation & Amortization (CF) at $3.7 million in Q4 2025, $3.6 million in Q3 2025, and $3.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.69 Mn |
| Dec 31, 2025 | 3.69 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | -5.84 Mn |
| Dec 31, 2023 | -5.84 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Sep 30, 2023 | 1.92 Mn |